Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide - PubMed (original) (raw)
Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide
Agnès Brouet et al. FASEB J. 2005 Apr.
Abstract
In tumors, caveolin-1, the structural protein of caveolae, constitutes a key switch through its function as a tumor suppressor and a promoter of metastases. In endothelial cells (EC), caveolin is also known to directly interact with the endothelial nitric oxide synthase (eNOS) and thereby to modulate nitric oxide (NO)-mediated processes including vasodilation and angiogenesis. In this study, we examined whether the modulation of the stoichiometry of the caveolin/eNOS complex in EC lining tumor blood vessels could affect the tumor vasculature and consecutively tumor growth. For this purpose, we used cationic lipids, which are delivery systems effective at targeting tumor vs. normal vascular networks. We first documented that in vitro caveolin transfection led to the inhibition of both VEGF-induced EC migration and tube formation on Matrigel. The DNA-lipocomplex was then administered through the tail vein of tumor-bearing mice. The direct interaction between recombinant caveolin and native eNOS was validated in coimmunoprecipitation experiments from tumor extracts. A dramatic tumor growth delay was observed in mice transfected with caveolin- vs. sham-transfected animals. Using laser Doppler imaging and microprobes, we found that in the early time after lipofection (e.g., when macroscopic effects on the integrity of the tumor vasculature were not detectable), caveolin expression impaired NO-dependent tumor blood flow. At later stages post-transfection, a decrease in tumor microvessel density in the central core of caveolin-transfected tumors was also documented. In conclusion, our study reveals that by exploiting the exquisite regulatory interaction between eNOS and caveolin and the propensity of cationic lipids to target EC lining tumor blood vessels, caveolin plasmid delivery appears to be a safe and efficient way to block neoangiogenesis and vascular function in solid tumors, independently of any direct effects on tumor cells.
Similar articles
- Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O. Sonveaux P, et al. Circ Res. 2004 Jul 23;95(2):154-61. doi: 10.1161/01.RES.0000136344.27825.72. Epub 2004 Jun 17. Circ Res. 2004. PMID: 15205364 - Irradiation promotes Akt-targeting therapeutic gene delivery to the tumor vasculature.
Sonveaux P, Frérart F, Bouzin C, Brouet A, Dewever J, Jordan BF, Gallez B, Feron O. Sonveaux P, et al. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1155-62. doi: 10.1016/j.ijrobp.2006.11.031. Epub 2007 Feb 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17276618 - Vascular caveolin deficiency supports the angiogenic effects of nitrite, a major end product of nitric oxide metabolism in tumors.
Frérart F, Lobysheva I, Gallez B, Dessy C, Feron O. Frérart F, et al. Mol Cancer Res. 2009 Jul;7(7):1056-63. doi: 10.1158/1541-7786.MCR-08-0388. Epub 2009 Jun 30. Mol Cancer Res. 2009. PMID: 19567781 - Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G, Dessy C, Feron O. Rath G, et al. J Physiol Pharmacol. 2009 Oct;60 Suppl 4:105-9. J Physiol Pharmacol. 2009. PMID: 20083858 Review. - Molecular regulation of tumour angiogenesis by nitric oxide.
Ziche M, Morbidelli L. Ziche M, et al. Eur Cytokine Netw. 2009 Dec;20(4):164-70. doi: 10.1684/ecn.2009.0169. Eur Cytokine Netw. 2009. PMID: 20167555 Review.
Cited by
- Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds.
Jozic I, Abujamra BA, Elliott MH, Wikramanayake TC, Marjanovic J, Stone RC, Head CR, Pastar I, Kirsner RS, Andreopoulos FM, Musi JP, Tomic-Canic M. Jozic I, et al. Commun Biol. 2021 Jun 18;4(1):757. doi: 10.1038/s42003-021-02298-5. Commun Biol. 2021. PMID: 34145387 Free PMC article. - Vascular permeability and pathological angiogenesis in caveolin-1-null mice.
Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. Chang SH, et al. Am J Pathol. 2009 Oct;175(4):1768-76. doi: 10.2353/ajpath.2009.090171. Epub 2009 Sep 3. Am J Pathol. 2009. PMID: 19729487 Free PMC article. - The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond.
Egger AN, Rajabiestarabadi A, Williams NM, Resnik SR, Fox JD, Wong LL, Jozic I. Egger AN, et al. Exp Dermatol. 2020 Feb;29(2):136-148. doi: 10.1111/exd.14068. Epub 2020 Jan 10. Exp Dermatol. 2020. PMID: 31845391 Free PMC article. Review. - Regulation of Cell Signaling and Function by Endothelial Caveolins: Implications in Disease.
Sowa G. Sowa G. Transl Med (Sunnyvale). 2012;Suppl 8:001. doi: 10.4172/2161-1025.S8-001. Epub 2012 Jan 4. Transl Med (Sunnyvale). 2012. PMID: 26605130 Free PMC article. - Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment.
Dewever J, Frérart F, Bouzin C, Baudelet C, Ansiaux R, Sonveaux P, Gallez B, Dessy C, Feron O. Dewever J, et al. Am J Pathol. 2007 Nov;171(5):1619-28. doi: 10.2353/ajpath.2007.060968. Epub 2007 Oct 4. Am J Pathol. 2007. PMID: 17916598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical